Abstract: Generating drug-like molecules that specifically bind to target proteins remains a resource-intensive challenge. Many studies focus on designing effective networks to accurately extract ...
Morning Overview on MSN
AI model reconstructs molecules from Coulomb explosion fragments
Researchers at the Department of Energy’s SLAC National Accelerator Laboratory have built a generative AI model that ...
- In a head-to-head cyclic adenosine monophosphate (cAMP) activation assay vs. eloralintide, oral small molecule amylin receptor agonist ASC39 demonstrated similar selectivity and potency to that of ...
To build a self-supervised magnetic resonance imaging (MRI) foundation model from routine clinical scans and to test whether it can support key glioma-related applications, including post-therapy ...
AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. By Carl Zimmer In 2024, two scientists from Google DeepMind ...
Researchers at Rice University and Oak Ridge National Laboratory have unveiled a physics-based model of magnetic resonance relaxation that bridges molecular-scale dynamics with macroscopic magnetic ...
Two teenage founders walked into Y Combinator co-founder Paul Graham’s backyard with an idea no one in agriculture seemed to want — an AI model to help design better pesticides. By the time they left, ...
Brown dwarfs: too small to be stars, too big to be planets. Only discovered in the 1990s, these in-between cosmic objects aren’t big enough to burn as hot and bright as a true star, instead usually ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Tesla has updated its Model Y electric SUV for 2026 with new styling and features. Despite the changes, the 2026 Model Y still drives and operates much like its predecessor. The changes for 2026 ...
Abstract: Molecular communication (MC) research is increasingly focused on applications within the human body, such as health monitoring and drug delivery, which require testing in realistic and ...
This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results